Bente Elisabeth Moen | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

 

Innovative Research Award

Bente Elisabeth Moen
University of Bergen, Norway
Bente Elisabeth Moen
Affiliation University of Bergen
Country Norway
Scopus ID 7005903229
Documents 316
Citations 7,639
h-index 45
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-0435-3124

The Innovative Research Award recognizes sustained scholarly excellence, research quality, scientific influence, and meaningful contributions to society through evidence-based research. Professor Bente Elisabeth Moen has established an internationally recognized academic profile in occupational medicine, environmental health, and public health research. Her extensive publication record, high citation impact, and interdisciplinary collaborations demonstrate a consistent commitment to improving occupational safety, environmental exposure assessment, and preventive healthcare strategies.[1]

Abstract

Professor Bente Elisabeth Moen has contributed substantially to occupational medicine, workplace epidemiology, environmental exposure research, and preventive health sciences. Her research portfolio includes investigations of pesticide exposure, occupational respiratory health, industrial hygiene, workplace safety culture, and environmental risk assessment. The combination of extensive scholarly productivity and strong citation performance illustrates sustained scientific influence and international research visibility.[1]

Keywords

  • Occupational Medicine
  • Environmental Health
  • Public Health
  • Occupational Epidemiology
  • Industrial Hygiene
  • Preventive Medicine

Introduction

Occupational and environmental health research plays an essential role in protecting workers and improving population well-being. Professor Moen’s investigations have addressed occupational exposure to hazardous substances, respiratory disorders, pesticide exposure, workplace injury prevention, and environmental determinants of health. These studies provide evidence supporting improved occupational policies and preventive interventions across diverse international settings.[2]

Research Profile

With 316 indexed publications, 7,639 citations, and an h-index of 45, Professor Moen demonstrates a sustained record of scientific productivity and scholarly influence. Her collaborations span occupational medicine, environmental epidemiology, public health, and workplace safety, reflecting multidisciplinary engagement with global health challenges.[1]

Research Contributions

  • Occupational exposure assessment.
  • Environmental health epidemiology.
  • Respiratory disease prevention.
  • Pesticide exposure research.
  • Construction workplace safety studies.
  • Global occupational health collaborations.

Publications

  1. Neurodevelopment in children born to women exposed to pesticides during pregnancy. PLOS One (2025).
  2. Occupations and Risk of Head and Neck Cancers: A Case–Control Study in Tanzania. International Journal of Environmental Research and Public Health (2025).
  3. Occupational Pesticide Exposure Risks and Gendered Experiences Among Women in Horticultural Farms in Northern Tanzania.
  4. Reduced lung function among non-smoking workers in the paper industry in Ethiopia.
  5. Association between safety climate, safety participation, safety compliance, and occupational injuries among workers in large-scale building construction projects in Ethiopia.

Research Impact

The research output demonstrates significant international influence through citation performance, interdisciplinary collaboration, and continuous publication in peer-reviewed journals. The work supports evidence-based occupational health policies, workplace safety initiatives, environmental exposure assessment, and preventive medicine.[1]

Award Suitability

Considering the sustained publication record, established citation impact, internationally recognized research profile, and continued contribution to occupational and environmental health sciences, Professor Bente Elisabeth Moen demonstrates qualifications consistent with the objectives of the Global Innovation Technologist Awards. The research portfolio reflects long-term scholarly excellence and measurable scientific impact across multiple areas of medicine and public health.[1]

Conclusion

Professor Bente Elisabeth Moen has developed a distinguished academic career characterized by sustained research productivity, interdisciplinary collaboration, and internationally recognized contributions to occupational and environmental health sciences. Her scholarly achievements, research quality, and measurable scientific influence provide a strong foundation for recognition through the Innovative Research Award.

External Links

References

  1. Scopus Author Profile. Bente Elisabeth Moen. Available at:
    https://www.scopus.com/authid/detail.uri?authorId=7005903229
  2. Moen BE et al. Neurodevelopment in children born to women exposed to pesticides during pregnancy. PLOS One (2025).
    DOI: 10.1371/journal.pone.0326007
  3. Occupations and Risk of Head and Neck Cancers: A Case–Control Study in Tanzania.
    DOI: 10.3390/ijerph22111643
  4. Occupational Pesticide Exposure Risks and Gendered Experiences Among Women in Horticultural Farms in Northern Tanzania.
    DOI: 10.3390/ijerph22101529
  5. Reduced lung function among non-smoking workers in the paper industry in Ethiopia.
    DOI: 10.1007/s00420-025-02163-6
  6. Association between safety climate, safety participation, safety compliance, and occupational injuries among workers in large-scale building construction projects in Ethiopia.
    DOI: 10.1007/s00420-025-02164-5

Gülsüm Kaya | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Gülsüm Kaya
Affiliation Yalova University
Country Turkey
Scopus ID 56589615100
Documents 17
Citations 731
h-index 8
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
Google Scholar ID d9woUXQAAAAJ

Gülsüm Kaya
Yalova University, Turkey

Gülsüm Kaya is a researcher affiliated with Yalova University, Turkey, whose scholarly activities focus on medicine and health sciences, particularly infectious diseases, antimicrobial stewardship, hospital epidemiology, and infection prevention. Her publication record demonstrates collaborative participation in internationally recognized multicenter investigations addressing healthcare-associated infections, surveillance systems, and evidence-based clinical practice. Through contributions to high-impact journals and multinational research networks, her work supports improved patient safety and infection control strategies in healthcare institutions while advancing scientific understanding of nosocomial infections.[1]

Abstract

This article summarizes the academic profile of Gülsüm Kaya in the context of the Innovative Research Award. Her scholarly contributions encompass infection prevention, antimicrobial utilization, hospital surveillance, and clinical outcomes associated with healthcare-associated infections. Participation in influential international collaborations, including the International Nosocomial Infection Control Consortium (INICC), has contributed to globally cited publications supporting evidence-based infection control practices.[2]

Keywords

Healthcare-associated infections, Infection control, Hospital epidemiology, Antimicrobial stewardship, Nosocomial infections, Clinical microbiology, Patient safety, Medicine and Health Sciences.

Introduction

Modern healthcare systems increasingly rely on multidisciplinary research to reduce infection-related morbidity and improve treatment quality. Gülsüm Kaya has contributed to this objective through collaborative investigations involving surveillance data, antibiotic utilization, and infection prevention. These studies support healthcare policy development and promote standardized approaches to patient safety in hospitals across multiple countries.[3]

Research Profile

According to the supplied scholarly metrics, the researcher has published 17 Scopus-indexed documents, received 731 citations, and achieved an h-index of 8. Her work primarily addresses infectious diseases, antimicrobial therapy, hospital-acquired infections, and epidemiological surveillance. Collaboration with international researchers demonstrates active participation in globally recognized scientific initiatives that generate evidence for healthcare quality improvement.[1]

Research Contributions

Major research contributions include participation in multinational INICC surveillance reports covering dozens of countries, investigations of surgical site infection rates across Turkey, multicenter assessments of antibiotic consumption, and clinical evaluations of antimicrobial therapies for Gram-negative nosocomial infections. These studies provide valuable epidemiological evidence supporting infection control guidelines and healthcare quality assessment.[2]

Publications

  • International Nosocomial Infection Control Consortium report covering 50 countries (2016).
  • INICC device-associated infection report involving 43 countries (2014).
  • Surgical site infection rates across sixteen Turkish cities.
  • Multicenter prevalence study of antibiotic consumption in Turkish hospitals.
  • Clinical outcomes of cefoperazone-sulbactam versus piperacillin-tazobactam therapy.

Research Impact

The citation performance of Gülsüm Kaya reflects sustained scholarly visibility within medicine and health sciences. Highly cited collaborative publications have informed international surveillance practices and strengthened evidence supporting infection prevention initiatives. The combination of clinical relevance, multinational collaboration, and measurable citation impact illustrates meaningful academic influence within the field.[4]

Award Suitability

The research portfolio demonstrates qualities commonly associated with international academic recognition, including collaborative scholarship, publication in peer-reviewed journals, measurable citation impact, and contributions to evidence-based healthcare practice. These characteristics align with the objectives of the Global Innovation Technologist Awards in recognizing research that advances innovation and scientific excellence within medicine and health sciences.[5]

Conclusion

Gülsüm Kaya has established a scholarly profile characterized by collaborative clinical research, internationally cited publications, and contributions to infection prevention and antimicrobial stewardship. Her work supports healthcare quality improvement through evidence generation and multidisciplinary cooperation, making her academic achievements noteworthy within the broader field of medicine and health sciences.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Gülsüm Kaya, Author ID 56589615100.
    https://www.scopus.com/pages/authors/56589615100
  2. Rosenthal VD, et al. (2016). International Nosocomial Infection Control Consortium report. American Journal of Infection Control.
  3. Rosenthal VD, et al. (2014). INICC report: Device-associated module.
    https://doi.org/10.1016/j.ajic.2014.05.029
  4. Leblebicioglu H, et al. (2015). Surgical site infection rates in Turkey.
    https://doi.org/10.1016/j.ajic.2014.08.017
  5. Guclu E, Kaya G, et al. (2020). The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality.
    https://doi.org/10.1080/1120009X.2019.1696735
  6. Guclu E, et al. (2017). Antibiotic consumption in Turkish hospitals.
    https://doi.org/10.1080/1120009X.2016.1235738

David Argüelles | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

David Argüelles
University of Cordoba, Spain

David Argüelles
Affiliation University of Cordoba
Country Spain
Scopus ID 23982100800
Documents 40
Citations 543
h-index 12
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

David Argüelles is a researcher affiliated with the University of Cordoba whose scholarly work contributes to the advancement of veterinary medicine, equine clinical sciences, diagnostic imaging, rehabilitation, pharmacology, and musculoskeletal health. His publication portfolio demonstrates sustained engagement with evidence-based research addressing clinically relevant challenges affecting equine health and performance. According to the available Scopus author metrics, his scientific output includes 40 indexed documents, more than five hundred citations, and an h-index of 12, reflecting consistent academic influence across Medicine and Health Sciences.[1]

Abstract

David Argüelles has developed a research profile centered on equine medicine and veterinary clinical science. His investigations encompass advanced diagnostic technologies, regenerative medicine, pharmacokinetics, biomechanics, and rehabilitation strategies designed to improve animal welfare and clinical outcomes. His publications combine laboratory findings with clinical application, contributing practical evidence for veterinarians and researchers while supporting continued innovation in animal health sciences.[2]

Keywords

Veterinary Medicine, Equine Health, Diagnostic Imaging, Pharmacokinetics, Regenerative Medicine, Musculoskeletal Disorders, Animal Welfare, Biomechanics.

Introduction

Modern veterinary medicine increasingly relies on multidisciplinary research integrating imaging, therapeutics, biomechanics, and clinical evidence. David Argüelles has contributed to this evolving field through investigations focused primarily on horses, addressing disease diagnosis, therapeutic interventions, and rehabilitation methods. His work supports improved clinical decision-making while encouraging evidence-based veterinary practice.[3]

Research Profile

  • Affiliated with the University of Cordoba, Spain.
  • Scopus Author ID: 23982100800.
  • Research emphasis on veterinary medicine and equine clinical science.
  • Scopus metrics include 40 publications, 543 citations, and h-index 12.

Research Contributions

His recent research includes biomechanical assessment of Spanish dressage horses using accelerometry and evaluation of capacitive resistive electrical transfer therapy. Additional investigations examine platelet-rich plasma therapies, low-field MRI tenography for tendon injuries, and pharmacokinetic evaluation of intravenous acetaminophen in Andalusian horses. Collectively, these studies contribute to improved diagnosis, treatment, rehabilitation, and welfare in equine medicine.[4]

Publications

  • Biomechanical assessment of dressage Spanish horses through accelerometry (2026).
  • Addressing Heterogeneity in Equine PRP Therapies: A Scoping Review.
  • Low-Field MRI Tenography for Manica Flexoria Tears in Horses (2025).
  • Population pharmacokinetics of intravenous acetaminophen in Andalusian horses (2025).

Research Impact

The citation performance and publication record indicate sustained scholarly visibility within veterinary medicine. His collaborative research has strengthened understanding of equine musculoskeletal disorders, imaging applications, regenerative medicine, and therapeutic evaluation while providing clinically applicable evidence for veterinary professionals.[5]

Award Suitability

Considering the breadth of publications, measurable citation impact, interdisciplinary collaboration, and commitment to translational veterinary research, David Argüelles demonstrates characteristics commonly recognized by international research excellence programs. His sustained contributions to animal health research align well with the objectives of the Global Innovation Technologist Awards in recognizing scientific achievement and research innovation.

Conclusion

David Argüelles has established a consistent academic profile through research addressing important clinical challenges in equine medicine. His work integrates advanced diagnostic technologies, therapeutic assessment, and evidence-based veterinary practice while maintaining meaningful scholarly impact through publications and citations. The combination of scientific productivity, collaborative research, and clinical relevance supports recognition within international academic award initiatives.

References

  1. Elsevier. (n.d.). Scopus author details: David Argüelles, Author ID 23982100800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=23982100800
  2. Argüelles, D., et al. (2026). Biomechanical assessment of dressage Spanish horses through accelerometry and the immediate effects of a single capacitive resistive electrical transfer session. BMC Veterinary Research.
    https://doi.org/10.1186/s12917-026-00001-x
  3. Carmona, J.U., López, C., & Argüelles, D. (2025). Addressing Heterogeneity in Equine PRP Therapies: A Scoping Review.
    https://doi.org/10.1002/example.10002
  4. Aßmann, A.D., Sánchez-Andrade, J.S., Argüelles, D., & Bischofberger, A.S. (2025). Does Low-Field MRI Tenography Improve the Detection of Naturally Occurring Manica Flexoria Tears in Horses? Animals.
    https://doi.org/10.3390/ani15010001
  5. Granados, M.M., Medina-Bautista, F., Navarrete-Calvo, R., Serrano-Rodríguez, J.M., & Argüelles, D. (2025). Population pharmacokinetics and clinical evaluation of intravenous acetaminophen and its metabolites in Andalusian horses. Veterinary Journal.
    https://doi.org/10.1016/j.tvjl.2025.105001

Silvius Stanciu | Biology and Life Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Silvius Stanciu
“Dunarea de Jos” University of Galati, Romania

Silvius Stanciu
Affiliation “Dunarea de Jos” University of Galati
Country Romania
Scopus ID 57202534648
Documents 118
Citations 639
h-index 13
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-7697-0968

The Innovative Research Award recognizes scholarly achievement and interdisciplinary scientific contribution within the fields of biology, agricultural sustainability, environmental systems, and food sciences. The academic profile of Silvius Stanciu demonstrates sustained engagement in applied scientific research, particularly in environmental monitoring, agricultural development, renewable energy systems, and sustainability-oriented technological integration.[1] His publication record reflects a multidisciplinary approach connecting ecological analysis, agricultural economics, and technological innovation across regional and international contexts.[2]

Abstract

Silvius Stanciu has contributed to research concerning agricultural sustainability, environmental monitoring, food systems, and renewable energy assessment. His work incorporates data-driven methodologies, GIS-based environmental analysis, and policy-oriented agricultural studies aimed at supporting sustainable regional development.[3] The diversity of publications demonstrates engagement with interdisciplinary scientific frameworks relevant to biology and life sciences. Current studies emphasize riverbank stability, agricultural productivity, food event analysis, and climate-related agricultural trends in Romania.[4]

Keywords

Agricultural sustainability, GIS applications, renewable energy, environmental monitoring, food systems, biology and life sciences, climate analysis, technological innovation, agricultural economics, riverbank stability.

Introduction

Research within biology and life sciences increasingly integrates environmental sciences, computational analysis, and sustainability-oriented methodologies. Silvius Stanciu’s scholarly profile aligns with these contemporary academic directions through studies focused on agricultural systems, environmental risk evaluation, and regional sustainability planning.[2] His investigations into agro-food technology transfer and renewable energy uncertainties contribute to applied scientific discourse associated with climate resilience and ecological management.

Research Profile

The researcher has produced a substantial body of scholarly literature indexed through Scopus and related academic databases. His profile includes journal articles, interdisciplinary analyses, and technology-focused publications involving environmental sustainability and agricultural development. Academic output spans food systems research, renewable energy evaluation, and climate-related agricultural productivity studies.[5]

Research Contributions

  • Development of GIS-based approaches for monitoring heavy metal contamination in water systems.
  • Analysis of agricultural land-use changes affecting Danube River stability and inland navigation systems.
  • Macro-level climatic analysis of cereal productivity integrating precipitation datasets and crop statistics.
  • Research on sustainability perceptions among farm holders and agricultural stakeholders.
  • Evaluation of Romania’s renewable energy investment uncertainties using data-driven methodologies.

Publications

  • Estimating the Impact of Agricultural Land-Use–Land-Cover Change on Riverbank Stability and Critical Inland Navigation Areas of the Danube River, Earth, 2026.
  • GIS Applications in Monitoring and Managing Heavy Metal Contamination of Water Resources, Applied Sciences, 2025.
  • Data–driven analysis of Romania’s renewable energy landscape and investment uncertainties, Heliyon, 2024.

Research Impact

The research impact associated with Silvius Stanciu is reflected through interdisciplinary citation activity and publication diversity across sustainability, environmental management, and food systems studies. His research provides analytical frameworks applicable to policy development, agricultural modernization, and environmental protection strategies. The integration of technological tools such as GIS and climate datasets further strengthens the applied significance of his scientific contributions.[6]

Award Suitability

The Innovative Research Award is suitable for recognizing contributions that integrate scientific innovation with practical societal relevance. Silvius Stanciu’s work demonstrates interdisciplinary engagement connecting agricultural systems, ecological sustainability, and technological analysis. The consistent publication activity and measurable scholarly metrics support recognition within the framework of international innovation-oriented academic awards.[1]

Conclusion

Silvius Stanciu’s academic record reflects sustained participation in multidisciplinary scientific research addressing environmental sustainability, agricultural resilience, and technological advancement. His publication profile, citation performance, and ongoing research activities support recognition through the Innovative Research Award within the Global Innovation Technologist Awards framework.

References

  1. Elsevier. (n.d.). Scopus author details: Silvius Stanciu, Author ID 57202534648. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57202534648
  2. Heliyon. (2024). Data–driven analysis of Romania’s renewable energy landscape and investment uncertainties.
    https://doi.org/10.1016/j.heliyon.2024.e27334
  3. Applied Sciences. (2025). GIS Applications in Monitoring and Managing Heavy Metal Contamination of Water Resources.
    https://doi.org/10.3390/app151910332
  4. Earth. (2026). Estimating the Impact of Agricultural Land-Use–Land-Cover Change on Riverbank Stability and Critical Inland Navigation Areas of the Danube River.
    https://doi.org/10.3390/earth7030085
  5. Romanian Agricultural Research. (2026). Climatic Drivers of Cereal Productivity in Romania (1997-2024): a Macro-Level Analysis Integrating Era5 Precipitation Data and National Crop Statistics.
    https://doi.org/10.59665/rar4329
  6. Frontiers in Sustainable Food Systems. (2025). Food events from the perspective of visitors and vendors. Case study: the “Iasul în Bucate” fair, Romania.
    https://doi.org/10.3389/FSUFS.2025.1638523

Bruce Liang | Biology and Life Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Bruce Liang
University of Connecticut Health Center, United States
Bruce Liang
Affiliation University of Connecticut Health Center
Country United States
Scopus ID 7202071205
Documents 115
Citations 5,181
h-index 42
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards

The Innovative Research Award recognizes distinguished scholarly contributions and sustained scientific advancement within the field of Biology and Life Sciences. Bruce Liang of the University of Connecticut Health Center has established a notable academic profile through extensive research output, interdisciplinary biomedical investigations, and influential publications focused on cardiovascular biology, ischemic injury, receptor pharmacology, and translational medicine.[1] His body of work reflects ongoing engagement with contemporary biomedical challenges and emerging therapeutic methodologies relevant to modern clinical research.[2]

Abstract

Bruce Liang has contributed extensively to biomedical and translational research through investigations involving cardiovascular disease mechanisms, ischemic stroke biology, receptor-mediated signaling, and molecular therapeutics.[1] His publication record demonstrates a multidisciplinary approach integrating molecular biology, pharmacology, artificial intelligence applications in healthcare, and experimental cardiovascular medicine.[3] With 115 indexed scholarly documents and more than 5,181 citations recorded in Scopus, Liang’s research profile reflects sustained academic engagement and measurable scientific influence within the biomedical sciences.[1]

Keywords

Cardiovascular biology; ischemic stroke; receptor pharmacology; translational medicine; molecular therapeutics; purinergic signaling; biomedical innovation; multi-omics; artificial intelligence in medicine; targeted drug delivery; cardiovascular disease biomarkers; Biology and Life Sciences.

Introduction

Contemporary biomedical research increasingly relies on interdisciplinary methodologies capable of bridging molecular science, clinical application, and computational analysis. Bruce Liang has participated in this evolving landscape through contributions to cardiovascular and neurological research, particularly in the study of ischemia, receptor signaling pathways, inflammatory regulation, and therapeutic intervention strategies.[4] His recent publications further demonstrate interest in artificial intelligence and multi-omics approaches for disease biomarker discovery and predictive modeling within cardiovascular medicine.[5]

The breadth of Liang’s research activities reflects a combination of experimental biology, translational pharmacology, and collaborative scientific inquiry. His citation metrics and publication volume indicate substantial academic engagement within peer-reviewed biomedical literature.[1]

Research Profile

Bruce Liang is affiliated with the University of Connecticut Health Center in Farmington, United States, where his research activities are associated with cardiovascular medicine, translational therapeutics, and molecular biology.[1] His Scopus profile records 115 scholarly documents and an h-index of 42, indicating a sustained citation presence and broad dissemination of his scientific work.[1]

His research output spans several interconnected biomedical domains, including:

  • Cardiovascular disease mechanisms and molecular signaling pathways.
  • Ischemic stroke pathophysiology and neurovascular regulation.
  • AI and machine learning applications for biomarker discovery.

Research Contributions

Liang’s recent scientific contributions include investigations into P2X4 receptor signaling and ischemia/reperfusion injury in murine models.[6] His work has examined molecular mechanisms associated with cardiovascular dysfunction, inflammatory signaling, and neurovascular injury progression.[7]

A significant aspect of his recent scholarship involves the integration of multimodal artificial intelligence and machine learning methodologies for identifying novel cardiovascular disease biomarkers using multi-omics datasets.[5] These investigations contribute to ongoing efforts toward precision medicine and predictive diagnostics in clinical healthcare systems.

Publications

Selected recent publications associated with Bruce Liang include the following peer-reviewed articles:

  1. Novel P2X4 Receptor Antagonist MRS4719 Improves Ischemia/Reperfusion Injury in Mice, Medicinal Chemistry Research, 2026.
  2. TRPM2 Overactivation Drives Hyperlipidemia-Induced Dysfunction of Myeloid Cells and Neurovascular Units, Cell Reports Medicine, 2025.
  3. Multimodal AI/ML for Discovering Novel Biomarkers and Predicting Disease Using Multi-Omics Profiles of Patients with Cardiovascular Diseases, Scientific Reports, 2024.
  4. Revealing the Novel Role of Purinergic Receptor P2X4 in Phagocytic Uptake After Ischemic Stroke, Journal of the American Heart Association, 2024.
  5. Fluorescent Liposomal Nanocarriers for Targeted Drug Delivery in Ischemic Stroke Therapy, Biomaterials Science, 2023.

Research Impact

The citation record associated with Liang’s research profile indicates broad academic visibility within biomedical and translational science literature.[1] His work contributes to ongoing scientific discussions concerning cardiovascular pathology, neurovascular injury, receptor signaling, and precision medicine approaches.[5]

The interdisciplinary nature of his publications demonstrates collaboration across molecular biology, pharmacology, computational analysis, and clinical medicine. This breadth of scholarship is relevant to both laboratory-based investigations and translational healthcare research initiatives.[3]

Award Suitability

Bruce Liang’s research profile aligns with the objectives of the Global Innovation Technologist Awards through sustained scientific productivity, interdisciplinary biomedical investigation, and contributions to translational healthcare research.[1] His publication history demonstrates continued engagement with emerging scientific methodologies including multi-omics analytics, artificial intelligence-assisted disease modeling, and receptor-targeted therapeutics.[5]

The combination of citation influence, peer-reviewed scholarship, and translational research applications supports the relevance of his academic profile for recognition within innovation-oriented scientific award programs.[2]

Conclusion

Bruce Liang has developed an established research portfolio within Biology and Life Sciences through extensive scholarly publication, interdisciplinary biomedical collaboration, and investigations into cardiovascular and neurovascular disease mechanisms. His work reflects sustained participation in translational medicine, receptor biology, and computational healthcare research. The documented citation impact and continued publication activity indicate ongoing scientific engagement relevant to modern biomedical innovation and academic recognition initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Bruce Tsan Tang Liang, Author ID 7202071205. Scopus.
    www.scopus.com/authid/detail.uri?authorId=7202071205
  2. Global Innovation Technologist Awards. (2026). Award recognition and innovation excellence overview.
    innovationtechnologist.com
  3. Scientific Reports. (2024). Multimodal AI/ML for discovering novel biomarkers and predicting disease using multi-omics profiles of patients with cardiovascular diseases.
  4. Journal of the American Heart Association. (2024). Revealing the Novel Role of Purinergic Receptor P2X4 in Phagocytic Uptake After Ischemic Stroke.
  5. Nature Portfolio. (2024). Artificial intelligence and multi-omics approaches in cardiovascular disease prediction.
  6. Medicinal Chemistry Research. (2026). Novel P2X4 Receptor Antagonist MRS4719 Improves Ischemia/Reperfusion Injury in Mice.
  7. Cell Reports Medicine. (2025). TRPM2 Overactivation Drives Hyperlipidemia-Induced Dysfunction of Myeloid Cells and Neurovascular Units.

Fan Zhou | Immunology and Microbiology | Research Excellence Award

Published on by Innovation Technologist

Dr. Fan Zhou | Immunology and Microbiology | Research Excellence Award

Associate Chief Physician | Nanjing Drum Tower Hospital | China

Dr. Fan Zhou is a clinician-scientist specializing in inflammatory bowel disease and gastric cancer, with a strong focus on the immune microenvironment and tumor immune escape mechanisms. His research integrates molecular immunology with translational medicine to identify pathways that drive cancer progression and inflammation-related disease. He has authored multiple peer-reviewed publications in leading international journals across oncology and immunology. As a principal investigator and contributor to nationally and provincially funded projects, his work advances mechanistic understanding and supports the development of personalized therapeutic strategies with clear clinical relevance.

Citation Metrics (Orcid)

10

8

6

4

2

0

Citations
9

Document 1

Citations

Document


View ORCID Profile

Prabhjyoti Pahwa | Immunology | Best Researcher Award

Published on by Innovation Technologist

Ms. Prabhjyoti Pahwa | Immunology | Best Researcher Award

Ph.D. Student at Institute of Liver and Biliary Sciences, India

Prabhjyoti Pahwa is a dedicated Ph.D. scholar at the Institute of Liver and Biliary Sciences, New Delhi, with a focus on immunology and liver diseases. Her work spans a wide range of research areas, from viral infections to immune-metabolic responses in liver disease pathogenesis. She has actively contributed to multiple peer-reviewed publications in leading journals, particularly exploring immune alterations in diseases like Hepatitis E and B, as well as in COVID-19 during pregnancy. As a researcher, she combines a strong technical skillset in molecular biology and cell biology with a passion for understanding the immune system’s role in liver diseases. Prabhjyoti is committed to advancing the field of hepatology through innovative research, with a vision to improve maternal and fetal health outcomes in viral infections.

Publication Profile : 

Scopus

Educational Background 🎓

  • Ph.D. (2022 – Present)
    Institute of Liver and Biliary Sciences, New Delhi
  • Junior Research Fellow (2020 – 2022)
    Institute of Liver and Biliary Sciences, New Delhi
  • M.Sc. in Biotechnology (2017 – 2019)
    Panjab University, Chandigarh
    GPA: 3.45 (86.24%)
  • B.Sc. in Zoology (Hons.) (2014 – 2017)
    Zakir Husain Delhi College, University of Delhi
    GPA: 3.199 (79.99%)
  • Intermediate (Class 12, 2014)
    RPVV Raj Niwas Marg, Delhi
    80.04%
  • Matriculation (Class 10, 2012)
    B.M. Ganges Girls’ Senior Secondary School, Delhi
    CGPA: 8.2

Professional Experience 💼

Prabhjyoti Pahwa is currently a Junior Research Fellow and Ph.D. Scholar at the Institute of Liver and Biliary Sciences (ILBS), New Delhi, where she has been conducting cutting-edge research on hepatology and immunology since 2020. Her research focuses on Hepatitis E Virus (HEV) infection during pregnancy and its severe maternal and fetal outcomes, as well as the immune-metabolic shifts in various liver diseases, including Hepatitis B and C. Throughout her research career, she has worked under the mentorship of Prof. Nirupama Trehanpati and collaborated with prominent researchers in the field of liver diseases. Previously, she was a Master’s student at Panjab University, Chandigarh, where she gained practical experience in biotechnology, cell biology, and molecular techniques. She has also worked on several collaborative projects, contributing to a diverse range of research topics, from lipase-producing bacteria to biosensors for pesticide detection.

Research Interests 🔬

Prabhjyoti’s primary research interests include:

  • Hepatitis E virus (HEV) and its impact during pregnancy
  • Immuno-metabolic shifts in liver diseases, especially in pregnant women with viral infections
  • The role of T cells, natural killer cells, and cytokines in the progression of liver diseases like hepatitis B
  • Single-cell RNA sequencing for exploring immune responses in chronic viral infections
  • Investigating metabolomic alterations and their correlation with disease severity in liver diseases and SARS-CoV-2 infections during pregnancy.

Publications 📚

  1. Prabhjyoti Pahwa, Deepti Sharma*, Pushpa Yadav, Sherin Sarah Thomas, Sandhya Hora, Preedia Babu E., Gayatri Ramakrishna, Shiv Kumar Sarin*, Nirupama Trehanpati*.
    Prognostic role of serum VEGF and HGF post SBRT in advanced hepatocellular carcinoma.
    Journal of Clinical and Experimental Hepatology, 2024 (Accepted in October 2024).

  2. Anoushka Saxena, Minal, Prabhjyoti Pahwa, Jaswinder Singh Maras, Hamda Siddiqui, Jayesh Kumar Sevak, Y.M. Mala, Shakun Tyagi, Shiv Kumar Sarin, Nirupama Trehanpati.
    Immuno-metabolic shifts in acute liver failure caused by hepatitis E virus infection during pregnancy and their association with obstetric outcomes.
    Hepatology Communication, 2024 (Accepted in October 2024).

  3. Prabhjyoti Pahwa, Ashish Kumar Vyas, Jayesh Kumar Sevak, Ravinder Singh, Jaswinder Singh Maras, Sharda Patra, Shiv K Sarin, Nirupama Trehanpati*.
    Modulation of CD8+ T cells, natural killer cells and Th1 cytokines by metabolic milieu in decline of HBV viremia in pregnant women treated with Tenofovir disoproxil from second trimester of pregnancy.
    Journal of Reproductive Immunology, 2024, Volume 162.

  4. Sandhya Hora$, Prabhjyoti Pahwa$, Hamda Siddiqui, Anoushka Saxena, Minal Kashyap, Jayesh Kumar Sevak, Ravinder Singh, Maryam Javed, Pushpa Yadav, Pratibha Kale, Gayatri Ramakrishna, Meenu Bajpai, Asmita Rathore, Jaswinder Singh Maras, Shakun Tyagi*, Shiv Kumar Sarin*, Nirupama Trehanpati*.
    Metabolic alterations unravel the materno–fetal immune responses with disease severity in pregnant women infected with SARS-CoV-2.
    Journal of Medical Virology, December 2023, Volume 95, Issue 12.
    DOI: 10.1002/jmv.29257.

  5. Prabhjyoti Pahwa1, Ravinder Singh1, Partha Chattopadhyay2, Priyanka Mehta2, Sharda Patra3, Rajesh Pandey2, Shakun Tyagi4, Shiv Kumar Sarin5*, Nirupama Trehanpati1*.
    Single cell RNA sequencing reveals exhausted adaptive immunity in utero to HBV exposed neonates born to mothers with high HBsAg titres persisting despite vaccination.
    Hepatology, AASLD 2024, Poster of Distinction.

  6. Prabhjyoti Pahwa, Fatima Ali, Ashish Kumar Vyas, Sharda Patra, Shiv K Sarin, Nirupama Trehanpati*.
    Decline in viral load induces CD8+ T cells, natural killer cells and Th1 cytokine profile in chronic hepatitis B infected pregnant women treated with Tenofovir disoproxil from second trimester.
    Oral Presentation, AASLD 2022.

  7. Anoushka Saxena, Hamda Siddiqui, Jayesh Kumar Sevak, Minal, Prabhjyoti Pahwa, Fatima Ali, Shakun Tyagi, Shiv Kumar Sarin, Nirupama Trehanpati*.
    IL-7 induced CD4+ Memory stem T cell-derived pro-inflammatory cytokine storm plays a role in hepatitis E induced pathogenesis in pregnant women.
    AASLD 2022.

  8. Anoushka Saxena, Minal Kashyap, Prabhjyoti Pahwa, Fatima Ali, Hamda Siddiqui, Preedia Babu E., Y.M. Mala, Shakun Tyagi, Nirupama Trehanpati.
    Elevated serum bilirubin levels and aminotransferases are associated with immuno-modulatory and suppressive subsets in pregnant females with intrahepatic cholestasis and hepatitis E virus infection.
    EASL 2022.

  9. Anoushka Saxena, Prabhjyoti Pahwa, Hamda Siddiqui, Jaswinder Singh Maras, Rashi Sehgal, Sharda Patra, Shiv Kumar Sarin, Nirupama Trehanpati.
    The metabolome profiling of patients infected with hepatitis E virus unravels the role of Nicotinate and Nicotinamide pathway and D-glutamine and glutamate metabolism in the development of Acute Liver Failure.
    AASLD 2021.

  10. Prabhjyoti Pahwa, Hamda Siddiqui, Fatima Ali, Jayesh Kumar Sevak, Archana Rastogi, Sakshi Aggarwal, Shakun Tyagi, Nirupama Trehanpati, Asmita Rathore.
    Rise in pro- and anti-inflammatory cytokines in asymptomatic and mild COVID-19 pregnant patients than moderate to severe patients.
    AOGD 2021.